NSCLC, RECURRENT
Clinical trials for NSCLC, RECURRENT explained in plain language.
Never miss a new study
Get alerted when new NSCLC, RECURRENT trials appear
Sign up with your email to follow new studies for NSCLC, RECURRENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo aims to boost immunotherapy in tough lung cancers
Disease control Recruiting nowThis study tests whether adding pirfenidone to the immunotherapy drug atezolizumab can help shrink tumors and overcome treatment resistance in people with stage 4 or recurrent non-small cell lung cancer. About 25 adults who have already had at least one prior treatment will recei…
Matched conditions: NSCLC, RECURRENT
Phase: PHASE1, PHASE2 • Sponsor: University of Kansas Medical Center • Aim: Disease control
Last updated May 26, 2026 05:37 UTC
-
Smart CAR t cells aim to outsmart solid tumors in new trial
Disease control Recruiting nowThis study tests a new type of CAR T cell therapy for adults with advanced solid tumors, including colorectal, pancreatic, lung, ovarian, and mesothelioma cancers. The therapy uses a patient's own immune cells, modified to recognize and attack cancer cells that have lost a specif…
Matched conditions: NSCLC, RECURRENT
Phase: PHASE1, PHASE2 • Sponsor: A2 Biotherapeutics Inc. • Aim: Disease control
Last updated May 22, 2026 14:01 UTC